<?xml version="1.0"?>
<Articles JournalTitle="The Research in Heart Yield and Translational Medicine (RHYTHM)">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>06</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study</title>
    <FirstPage>107</FirstPage>
    <LastPage>113</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Samira</FirstName>
        <LastName>Taravatmanesh</LastName>
        <affiliation locale="en_US">Department of Epidemiology, School of Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Davood</FirstName>
        <LastName>Khalili</LastName>
        <affiliation locale="en_US">Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Soheila</FirstName>
        <LastName>Khodakarim</LastName>
        <affiliation locale="en_US">Department of Epidemiology, School of Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Samaneh</FirstName>
        <LastName>Asgari</LastName>
        <affiliation locale="en_US">Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farzad</FirstName>
        <LastName>Hadaegh</LastName>
        <affiliation locale="en_US">Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Fereidon</FirstName>
        <LastName>Azizi</LastName>
        <affiliation locale="en_US">Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Siamak</FirstName>
        <LastName>Sabour</LastName>
        <affiliation locale="en_US">Safety Promotions and Injuries Prevention Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>04</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>12</Month>
        <Day>24</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Several studies have emphasized the importance of cardiovascular disease (CVD) prevention. However, there is a dearth of data on the prevention of cardiovascular disease recurrence. The present study was the 1st in Iran to evaluate factors associated with CVD recurrence.&#xA0;&#xA0; 
Methods: This prospective cohort study was conducted on 483 subjects (&gt; 30 years old) with a history of CVD who participated in the Tehran Lipid and Glucose Study and were followed up for 12 years (1999&#x2013;2012). The relationships between the most important established risk factors for CVD and CVD recurrence were evaluated. 
Results: Totally, 258 (53.4%) men and 225(46.5%) women at a mean age of 59.2 &#xB1; 10.7 years were recruited in the study. Our results showed that over the 12-year follow-up, the incidence of a recurrent event (per 100 person-years) was 48.5. Further, after controlling the possible confounding factors, the following variables had a significant relationship with CVD recurrence: age (HR = 1.02; p value = 0. 001), male sex (HR = 1.4; p value = 0.012), smoking (HR = 1.7; p value = 0.004), and increased fasting blood sugar (HR = 2.1; p value = 0.001). 
Conclusion: We found that the established variables in the development of CVD (i.e., age, sex, and smoking) played an important role in the risk of CVD recurrence.&#xA0;</abstract>
    <web_url>https://rhythm.tums.ac.ir/index.php/jthc/article/view/528</web_url>
    <pdf_url>https://rhythm.tums.ac.ir/index.php/jthc/article/download/528/597</pdf_url>
  </Article>
</Articles>
